Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Blog
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cut Regulations and Get COVID-19 Drugs to Patients
Raymond March
-
April 8, 2020
San Francisco’s Vaping Ban Is Doomed To Go Up in Smoke
To Make Drugs More Affordable, President Trump Should Focus on Price Competition
Keep Government Out of Developing a COVID-19 Vaccine
Only Markets Can Alleviate Drug Shortages
More Executive Orders Will Not Fix Healthcare
Raymond March
-
May 21, 2020
0
Economy Prosperity or Pandemic Protection: Why Not Both?
Raymond March
-
April 15, 2020
0
The FDA Cannot Hire Staff with Starting Salaries of $160,000
John Graham
-
April 9, 2016
0
FDA Wants More Sunscreen Regulations, but Would Consumers Get Burned?
Raymond March
-
March 14, 2019
0
To Make Drugs More Affordable, President Trump Should Focus on Price...
Raymond March
-
June 24, 2020
0
Let Competition, Not Politicians, Bring Insulin Prices Down
Raymond March
-
February 20, 2019
0
Generic Insulin Now Available After Nearly One Hundred Years of Regulatory...
Raymond March
-
March 25, 2019
0
Is Right-to-Try Legislation a Bust? Time for a Second Opinion.
Raymond March
-
October 17, 2019
0
Politicians Still Misunderstand High Insulin Prices
Raymond March
-
February 5, 2020
0
FDA Approves Record Number of Generic Drugs in 2018
Raymond March
-
January 9, 2019
0
1
2
3
4
...
9
Page 3 of 9
Edit with Live CSS
